Scale-Up Manufacturing Overview
Scale-up manufacturing refers to the process of increasing production batch size from development or pilot scale to commercial scale while maintaining product quality, purity, and consistency. For peptide manufacturers, scale-up involves optimising synthesis resin loading, purification column dimensions, lyophilization cycle parameters, and filling line throughput.
ShiLai™ Healthcare's CDMO team works with OEM partners to plan and execute scale-up transitions, ensuring that analytical specifications and quality standards are maintained at each production scale.
Scale-Up Stages
Development batch
Small-scale synthesis for formulation development, analytical method development, and stability studies. Typically 1–10g peptide.
Pilot batch
Intermediate scale for process validation, packaging trials, and initial market supply. Typically 10–100g peptide.
Commercial batch
Full commercial-scale production for ongoing market supply. Volume and batch size determined by market demand and OEM agreement.
B2B OEM Projects Only
We are currently not accepting individual or retail customer orders.
Chat on WhatsApp